Preprocedural TIMI flow and mortality in patients with acute myocardial infarction treated by primary angioplasty
Giuseppe De Luca, MD*,
Nicolette Ernst, MD*,
Felix Zijlstra, MD, PhD, FACC*,
Arnoud W. J. van't Hof, MD, PhD*,
Jan C. A. Hoorntje, MD, PhD*,
Jan-Henk E. Dambrink, MD, PhD*,
A. T. Marcel Gosslink, MD, PhD*,
Menko-Jan de Boer, MD, PhD, FACC* and
Harry Suryapranata, MD, PhD*,*
* ISALA Klinieken, Hospital De Weezenlanden, Zwolle, the Netherlands
View larger version (17K):
[in a new window]
|
Figure 1 Bar graphs show the relationship between preprocedural Thrombolysis In Myocardial Infarction (TIMI) flow and one-year mortality in all patients, as well as in low- and high-risk patients. Black bars = TIMI flow grade 0 to 1; gray bars = grade 2; white bars = grade 3.
|
|
View larger version (26K):
[in a new window]
|
Figure 2 Kaplan-Meier survival curves according to preprocedural Thrombolysis In Myocardial Infarction (TIMI) flow in low- and high-risk patients. *Log-rank statistic = 9.3, p < 0.01 vs. TIMI flow grade 0 to 2.
|
|
View larger version (25K):
[in a new window]
|
Figure 3 Relationship between preprocedural Thrombolysis In Myocardial Infarction (TIMI) flow and mortality in high-risk patients, with relative risk and 95% confidence interval (CI), according to the study inclusion period, ischemic time, and stent use.
|
|
|
